# FDA Inspection 1136833 - UltraLinq Healthcare Solutions Inc - March 11, 2021

Source: https://www.keypedia.com/records/fda_inspections/ultralinq-healthcare-solutions-inc/04634b4d-df40-4572-8c6f-bfd821f00fdf
Source feed: FDA_Inspections

> FDA Inspection 1136833 for UltraLinq Healthcare Solutions Inc on March 11, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1136833
- Company Name: UltraLinq Healthcare Solutions Inc
- Inspection Date: 2021-03-11
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Office Name: Center for Devices and Radiological Health

## Related Documents

- [FDA Inspection 1136833 - 2021-03-11](https://www.keypedia.com/records/fda_inspections/ultralinq-healthcare-solutions-inc/14511828-f0d2-4a9a-9179-75057b9e55f4)
- [FDA Inspection 1040004 - 2018-01-30](https://www.keypedia.com/records/fda_inspections/ultralinq-healthcare-solutions-inc/85d71036-03e5-4fec-92be-587bf3692974)

Company: https://www.keypedia.com/companies/ultralinq-healthcare-solutions-inc/96a9c7d8-f393-4008-afce-261409e9788e

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7